Gleason Group, Inc. Gilead Sciences, Inc. Transaction History

Gleason Group, Inc.

$567 Million
Q4 2024

A detailed history of Gleason Group, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Gleason Group, Inc. holds 8,964 shares of GILD stock, worth $833,293. This represents 0.15% of its overall portfolio holdings.

Number of Shares

8,964

Previous 8,892 0.81%

Holding current value

$833,293

Previous $745,000 11.14%

% of portfolio

0.15%

Previous 0.14%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 13, 2025	BUY	$83.95 - $97.9 $6,044 - $7,048	72 Added 0.81%	8,964 $828,000
Q3 2024 Oct 15, 2024	BUY	$66.59 - $83.99 $332 - $419	5 Added 0.06%	8,892 $745,000
Q2 2024 Jul 12, 2024	BUY	$63.15 - $72.88 $10,988 - $12,681	174 Added 2.0%	8,887 $609,000
Q1 2024 Apr 12, 2024	BUY	$71.58 - $87.29 $6,513 - $7,943	91 Added 1.06%	8,713 $638,000
Q4 2023 Jan 19, 2024	BUY	$73.27 - $83.09 $5,861 - $6,647	80 Added 0.94%	8,622 $698,000
Q3 2023 Oct 12, 2023	BUY	$73.94 - $80.67 $6,210 - $6,776	84 Added 0.99%	8,542 $640,000
Q2 2023 Jul 20, 2023	BUY	$76.01 - $86.7 $6,232 - $7,109	82 Added 0.98%	8,458 $651,000
Q1 2023 Apr 14, 2023	BUY	$77.31 - $88.08 $5,952 - $6,782	77 Added 0.93%	8,376 $694,000
Q4 2022 Jan 11, 2023	BUY	$62.32 - $89.47 $4,487 - $6,441	72 Added 0.88%	8,299 $0
Q3 2022 Oct 11, 2022	BUY	$59.54 - $68.01 $5,537 - $6,324	93 Added 1.14%	8,227 $508,000
Q2 2022 Jul 13, 2022	BUY	$57.72 - $65.01 $5,425 - $6,110	94 Added 1.17%	8,134 $503,000
Q1 2022 Apr 22, 2022	BUY	$57.92 - $72.58 $5,618 - $7,040	97 Added 1.22%	8,040 $478,000
Q4 2021 Jan 18, 2022	BUY	$64.88 - $73.64 $4,930 - $5,596	76 Added 0.97%	7,943 $577,000
Q3 2021 Oct 12, 2021	BUY	$67.69 - $73.03 $5,347 - $5,769	79 Added 1.01%	7,867 $550,000
Q2 2021 Jul 27, 2021	BUY	$63.47 - $69.35 $5,077 - $5,548	80 Added 1.04%	7,788 $536,000
Q1 2021 Apr 14, 2021	BUY	$60.0 - $68.46 $124,980 - $142,602	2,083 Added 37.03%	7,708 $498,000
Q4 2020 Jan 28, 2021	BUY	$56.65 - $64.55 $3,738 - $4,260	66 Added 1.19%	5,625 $328,000
Q3 2020 Oct 15, 2020	BUY	$62.1 - $78.08 $345,213 - $434,046	5,559 New	5,559 $351,000

Others Institutions Holding GILD

# of Institutions

1,940

Shares Held

989M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $117B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gleason Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gleason Group, Inc. with notifications on news.

Account

Gleason Group, Inc. Gilead Sciences, Inc. Transaction History